Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	109.41	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	109.41	176.5	99.81	1.57	4.72
Cash Growth	-38.01%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	2.9	2.25	1.04	0.21	-
Total Current Assets	112.31	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.13	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	3.49	-
Other Long-Term Assets	1.51	0.7	-	-	-
Total Assets	113.95	179.53	100.84	5.26	4.72
Accounts Payable	1.28	0.73	2.75	2.01	0.01
Accrued Expenses	11.13	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	7.76	-
Other Current Liabilities	-	9.5	10	4.23	0.03
Total Current Liabilities	12.41	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	0.99	-	-
Total Liabilities	12.41	19.51	21.29	14.82	0.04
Common Stock	0.01	0.01	0	-	-
Additional Paid-In Capital	326.08	302.71	162.82	-	-
Retained Earnings	-224.55	-155.9	-103.49	-32.06	-7.82
Total Common Equity	101.54	146.82	59.33	-32.06	-7.82
Minority Interest	-	13.2	20.22	10	-
Shareholders' Equity	101.54	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	113.95	179.53	100.84	5.26	4.72
Total Debt	-	-	-	7.76	-
Net Cash (Debt)	109.41	176.5	99.81	-6.19	4.72
Net Cash Growth	-38.01%	76.84%	-	-	-
Net Cash Per Share	1.16	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	94.88	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	73.68	65.3	43.59	0.38	17.25
Working Capital	99.9	159.23	80.54	-13.04	4.68
Book Value Per Share	1.38	2.25	1.36	-83.59	-0.45
Tangible Book Value	101.54	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	1.38	2.25	1.36	-83.59	-0.45

Source: S&P Capital IQ. Standard template. Financial Sources.